Patients should now be screened for cannabis use before surgery, experts with the American Society for Regional Anesthesia and Pain Medicine said in a Jan. 3 news release. The updated guidelines recommend that physicians ask patients questions regarding their cannabis use, such as how much they use the drug, how often and via which method (such as smoking or edibles).
The guidelines come as legislation across the country seeks to decriminalize marijuana, the most commonly used drug in the U.S. aside from alcohol. Cannabis is now fully legal — medicinally and recreationally — in 21 states plus the District of Columbia, including Connecticut, which offered its first sales for recreational use on Tuesday.
According to Civiqs data, 69% of Pennsylvania voters across the political spectrum think pot should be legal. In Pennsylvania, only medical use is permitted.
About 17% of Pennsylvanians used cannabis in 2019 and 2020, a Statista survey found, though people could be underreporting due to the drug’s legal status in the state, which requires a medical marijuana ID card.
It’s within this changing landscape that anesthesiologists are weighing their need to know about patient consumption.
People who use cannabis may need more anesthesia to be put under for surgery and could experience more pain, not less, after surgery because of the way anesthesia and cannabis intermingle, said Dr. Samer Narouze, president of the American Society of Regional Anesthesia and Pain Medicine.
Read More
Anesthetic drugs, like propofol, activate the same pathway in the brain as cannabis called the endocannabinoid system, a network that connects multiple regions of the brain and drives pain management and reward. Both substances being present in the body can increase their side effects and change a person’s experience with pain.
Acute cannabis use (like smoking one to two hours before a surgery) can also increase heart rate at the same time anesthetics reduce blood pressure, said Dr. Benedict Alter, an anesthesiologist in the Division of Pain Medicine at UPMC St. Margaret, director of translational pain research, and an assistant professor of anesthesia and perioperative medicine at the University of Pittsburgh.
“If you have another drug, like cannabis, that puts the heart at risk, that’s less blood flow to the heart, and you have a double hit,” he said.
This is why it’s so important for patients to be forthcoming, and for physicians to ask questions. Dr. Narouze said if a patient used cannabis before the surgery, ASRA recommends postponing elective surgeries — one, to reduce risk of complications like arrhythmia and, two, because an altered patient cannot provide informed consent. Dr. Narouze is also the chairman of the Center for Pain Medicine at Western Reserve Hospital and a professor of surgery and anesthesiology at Northeast Ohio Medical University.
“There’s no harm in postponing elective surgery a few hours,” if a patient appears altered from cannabis before surgery, said Dr. Narouze. “If use is chronic, the doctor needs to inform them they might experience more pain after surgery and might not be as responsive to painkillers — there is crosstalk between the pathway cannabis activates in the brain and opioid pathways in the brain, shifting a chronic cannabis user’s reaction to opioid painkillers.”
The legal status of cannabis in Pennsylvania likely affects how comfortable people feel disclosing their use, he said.

“When the question is phrased as ‘do you use alcohol or illicit drugs,’ the patient may not see [cannabis] as illicit,” said Dr. Narouze. Instead of just asking yes or no, the guidelines suggest more detailed questions.
Cannabis is a Schedule I drug under the Controlled Substances Act, meaning it has a high potential for abuse and has “no accepted medical use in the U.S.” Cannabis sits in the same category as heroin and LSD (aka acid), with cocaine being Schedule II.
A House bill, called the Marijuana Opportunity Reinvestment and Expungement Act, was introduced in 2021 to remove cannabis from the Controlled Substances Act, halt criminal penalties and provide financial support for people impacted by the War on Drugs. The bill passed in the House last April but did not get a full vote in the Senate.
“People are less likely now than 20 years ago to keep cannabis use to themselves,” Dr. Alter said. Patients should think of cannabis use disclosure like they would any medical issue. And he noted that doctors are not required to report cannabis use — patients won’t get in legal trouble for telling their doctor, though if the patient displays signs of a substance use disorder, a clinician may direct them to additional resources.

Indeed, regional culture seems to play a part. DesiRae Cowham, 22, of Wilkinsburg, moved to Pittsburgh from California one year ago. “It’s like an entirely different world over here,” she said.
Cowham struggles with what she called a “mystery illness,” something that runs in her family and which she has an involved and dedicated care team for. In California, she used a cannabis medical card for pain relief and always disclosed her use to doctors. “Most people on my team thanked me for disclosing,” she said.
But shortly before getting an endoscopy in Pennsylvania, with the IV already in her arm and feeling nervous for the procedure, a doctor spoke at length about her cannabis use, telling her it was excessive and that her condition could be cannabis hyperemesis syndrome, which causes excessive vomiting, nausea and abdominal pain in chronic users. Cowham said the doctor was not part of her team and that condition had already been ruled out.
“I didn’t expect to have to defend that to the doctor, and I started bawling right before they wheeled me out,” she said. “It’s not going to prevent me from being open … but it put a really bad taste in my mouth,” said Cowham.
“I’m glad ASRA put out this recommendation,” said Dr. Alter. At the least, it highlights the issue of cannabis and anesthetic interactions, as well as patient comfort in disclosing. “It’s good to have a conversation with your anesthesiologist about anything concerning your health.”
Drs. Narouze and Alter both said more research needs to be done exploring different aspects of cannabis, such as consequences of chronic use on the body as well as pain management.
Among the needed research topics is the concentration of THC — the main intoxicating component of cannabis — which has increased dramatically in recent years. “This needs to be studied,” Dr. Narouze said, because higher concentrations change the effects on the body and how other drugs in the system interact.
“We hope the guidelines will serve as [a] roadmap to help better care for patients who use cannabis and need surgery,” said Dr. Narouze in the release.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.